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Summary Oxidative stress is one of the mechanisms with a central role involved in the
pathogenesis of myocardial infarction. The protective effect of glutamine on myocardial anti-
oxidant defense system was investigated during isoprenaline-induced myocardial infarction,
an animal model of myocardial infarction of human beings. Levels of diagnostic marker
enzymes in plasma, reduced glutathione (GSH) and lipid peroxides and the activities of
glutathione peroxidase, glutathione-S-transferase, catalase and superoxide dismutase in heart
tissue were determined. Injection of isoprenaline caused significant increases in the levels of
diagnostic marker enzymes in plasma and lipid peroxidation in heart tissue. A parallel decline
in the levels of ATP (Adenosine triphosphate) and GSH and the activities of glutathione-
dependent antioxidant enzymes and antiperoxidative enzymes in heart tissue was also
observed. Prior oral administration of glutamine significantly prevented isoprenaline-induced
adverse effects and maintained myocardial antioxidant status at near normal status. The
cardioprotective effect of glutamine is probably related to a strengthening of the myocardial
membrane by its membrane stabilizing action, or to a counteraction of free radicals by its
antioxidant property, or to its ability to maintain near to normal status the activities of free
radical scavenging enzymes and the level of GSH, which protect myocardial membrane
against oxidative damage by decreasing lipid peroxidation.
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Introduction
Myocardial infarction and the resultant abnormalities in
cardiac function represent the leading cause of morbidity and
mortality in developed countries [1]. However, with changing
life style in developing countries, like India, particularly in
urban areas, myocardial infarction is making an increasingly
important contribution to mortality statistics of such countries
[2]. It is well recognized that myocardial infarction is a
complex phenomenon affecting the mechanical, electrical,
structural and biochemical properties of the heart [3]. Despite
this complexity, impressive recent progress has been achieved
in advancing our understanding and appreciation of the
cellular processes and mechanistic bases underlying cardiac
dysfunction associated with myocardial infarction and most
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importantly, in applying this knowledge to therapeutic inter-
ventions.
Glutamine, a multifaceted amino acid used as an energy sub-
strate for most cells, is one of the principal free intracellular
amino acids in mammalian heart cells [4]. It is important as a
constituent of proteins and as a central metabolite for amino
acid transamination via α-ketoglutarate and glutamate. It
provides nitrogen for a number of biosynthetic pathways,
serving as a precursor of the purine and pyrimidine rings of
nucleic and nucleotides such as adenosine triphosphate
(ATP) [5]. Glutamine plays an important role in the nitrogen
and carbon-skeleton exchange among different tissues,
where this amino acid fulfils many different physiological
functions [6]. It has immuno-regulative and cell-regulative
capabilities, as recent investigations have shown [7]. It also
regulates endothelial nitric oxide metabolism in the heart tissue
[8]. One of the most important characteristics of glutamine is
that it plays a critical role in glutathione biosynthesis by
providing glutamate to the glutathione system, which is one
of the main sources of the antioxidant defense system in the
cell [9]. It is also involved in cell membrane stabilization,
antioxidation, detoxification, and energy production [4, 10,
11]. Significant reduction in the intracellular concentration
of glutamine has been reported to occur in the heart tissue
during myocardial infarction condition [12]. Though glutamine
is assumed to participate in various important biological and
physiological functions in heart, the protective effect of
glutamine on myocardial antioxidant defense system in
experimentally induced myocardial infarction condition has
not been explored in detail.
Myocardial infarction induced by isoprenaline [isopro-
terenol; L-β-(3,4-dihydroxyphenyl)-α-isopropylaminoethanol
hydrochloride], a β-adrenergic agonist, shows many meta-
bolic and morphologic aberrations in the myocardium of
experimental animals similar to those observed in myocardial
infarction in man [13]. Intraperitoneal administration of
isoprenaline produces necrotic lesions and increases lipid
peroxidation in the myocardium, which plays a significant
part in the pathogenesis of myocardial dysfunction [14].
Alterations in the activities of antiperoxidative enzymes
[superoxide dismutase (SOD) and catalase (CAT)] and
glutathione dependent antioxidant enzymes [glutathione per-
oxidase (GPX) and glutathione-S-transferase (GST)] have
been reported in experimentally induced myocardial infarction
in rats [15].
In the present study, we have investigated the cardio-
protective effects of glutamine on myocardial antioxidant
status in isoprenaline-induced myocardial infarction in rats by
virtue of its membrane stabilizing and antioxidant properties.
Materials and Methods
Chemicals
Epinephrine, glutamine, isoprenaline and tetraethoxy pro-
pane were obtained from M/s. Sigma Chemical Company, St.
Louis. MO. All the other chemicals used were of analytical
grade.
Animals
Male Wistar strain albino rats, weighing 120–150 g were
selected for the study. The animals were housed individually in
polyurethane cages under hygienic and standard environmental
conditions (28 ± 2ºC, humidity 60–70%, 12 h light/dark cycle).
The animals were allowed a standard diet [M/s Sai Feeds,
Bangalore, India] and water ad libitum. The experiment was
carried out as per the guidelines of Committee for the
Purpose of Control and Supervision of Experiments on
Animals (CPCSEA), New Delhi, India and approved by the
Institutional Animal Ethics Committee (IAEC).
Induction of myocardial infarction
The myocardial infarction was induced in experimental rats
by injecting isoprenaline [11 mg (dissolved in physiological
saline) 100 g−1 body weight day−1], i.p. for 2 days [16].
Experimental protocol
The experimental animals were divided into four groups,
comprising six rats each. Rats in Group I (normal control)
received standard diet for a period of 20 days. Group II
animals were orally administered with glutamine [100 mg
(dissolved in distilled water)/kg body weight/day] by intra-
gastric intubation for a period of 20 days. In Group III, rats
were injected with isoprenaline [11 mg (dissolved in physio-
logical saline) 100 g−1 body wt day−1], i.p. for 2 days for the
induction of myocardial infarction. In Group IV, the animals
were pretreated with glutamine [100 mg/kg body weight/
day, p.o for 20 days before the induction of myocardial
infarction as described for Group III. Control animals
(Group I and Group II) were injected with physiological
saline alone for 2 days.
At the end of the experimental period, i.e., 24 h after
last injection of isoprenaline, the experimental animals were
sacrificed blood was collected using heparin as anti-
coagulant and the plasma separated was used for the
determination of diagnostic marker enzymes. The heart
tissue was excised immediately and washed with chilled
isotonic saline. The heart tissue homogenates prepared in
ice-cold 0.1 M Tris-HCl buffer, pH 7.2 were used for the
determination of lipid peroxides (LPO), reduced glutathione
(GSH) and antioxidant enzymes.
Biochemical assays
The activities of alanine aminotransferase (ALT) [ECCardioprotective Effect of Glutamine
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2.6.1.2] and aspartate aminotransferase (AST) [EC 2.6.1.1]
in plasma were estimated by the method of Mohur and
Cook [17]. The lactate dehydrogenase (LDH) [EC 1.1.1.27]
activity in plasma was determined spectrophotometrically
according to the method of King [18]. The creatine phospho-
kinase (CPK) [EC 2.7.3.2] activity in plasma was assayed by
the method of Okinaka et al. [19]. The level of ATP in the
heart tissue was determined by the method of Ryder [20]
using Shimadzu LC 10 ATvp HPLC. Myocardial lipid
peroxides level was determined as TBA-reactive substances
by the method of Ohkawa et al. [21] and the GSH content
was estimated by the method of Ellman [22]. The method
described by Paglia and Valentine [23] was followed for the
assay of glutathione peroxidase [EC 1.11.1.9] activity and
glutathione-S-transferase (GST) [EC 2.5.1.18] activity was
determined by the method of Habig et al. [24]. Catalase
(CAT) [EC 1.11.1.6] activity was determined by the method
of Takahara et al. [25] and the method described by Misra
and Fridovich [26] was adopted for the determination of
superoxide dismutase (SOD) [EC 1.15.1.1] activity. The
protein content was determined by the method of Lowry et
al. [27].
Statistical analysis
Results are expressed as mean ± SD. Multiple comparisons
of the significant ANOVA were performed by Tukey’s
multiple comparison test. A p-value <0.05 was considered as
statistically significant. All data were analyzed with the aid
of statistical package program SPSS 10.0 for Windows.
Results
Table 1 depicts the levels of diagnostic marker enzymes
(AST, ALT, LDH and CPK) in the plasma of normal and
experimental groups of rats. There was a significant (p<0.001)
increase noticed in the levels of these marker enzymes in the
plasma of Group III isoprenaline-induced myocardial
infarcted rats as compared to that of Group I control rats.
The oral pre-treatment with glutamine significantly (p<0.001)
prevented the isoprenaline-induced release of these enzymes
from the myocardium into the systemic circulation and
maintained the rats at near normal status, indicating the
cytoprotective action of glutamine. Figure 1 shows the level
of myocardial ATP content in normal and experimental
groups of rats. Significant (p<0.001) reduction in the level of
ATP content in the heart tissue of Group III myocardial
infarction induced rats as compared to that of Group I
control animals. The prior administration of glutamine main-
tained the level of ATP at near normalcy in Group IV rats as
compared to that of Group III myocardial infarction induced
rats, reflecting its ability to maintain the function of the heart
mitochondria at near normal status.
Table 2 depicts the levels of lipid peroxides and reduced
glutathione and the activities of glutathione dependent
antioxidant enzymes (GPx and GST) and antiperoxidative
enzymes in the heart tissue of normal and experimental
groups of rats. There was a significant (p<0.001) increase in
the level of lipid peroxidation along with a concomitant
decline in the level of GSH noted in the heart tissue of Group
III isoprenaline-administered rats as compared to controls.
Also a significant (p<0.001) reduction in the activities of
glutathione dependent antioxidant enzymes (GPx and GST)
Table 1. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST),
lactate dehydrogenase (LDH), and creatine phosphokinase (CPK) in plasma of
normal and experimental groups of rats.
Parameters Control Glutamine (A) Isoprenaline (B) (A + B)
ALT 92.4 ± 8.71 90.8 ± 8.25 349 ± 27.6a,b 118 ± 9.54c,d,e
AST 89.3 ± 6.42 82.7 ± 6.86 376 ± 23.9a,b 124 ± 8.35c,f,g
LDH 176 ± 12.2 182 ± 11.7 345 ± 21a,b 198 ± 14.2c,d,e
CPK 125 ± 8.54 118 ± 9.23 327 ± 17.1a,b 143 ± 9.7c,d,e
(A): Glutamine, 100 mg/kg body wt/day, p.o. for 20 days.
(B): Isoprenaline, 11 mg/100 g body wt/day, i.p. for 2 days.
Results are mean ± SD of six animals. Values expressed: ALT, AST, and LDH, µmol
pyruvate liberated h−1l−1; CPK, µmol creatine liberated h−1l−1.  ap<0.001 significantly
different compared with control animals; bp<0.001 significantly different compared with
glutamine-administered normal rats; cp<0.001 significantly different compared with
isoprenaline-induced myocardial infarcted rats; dp<0.05 significantly different compared
with control animals; ep<0.05 significantly different compared with glutamine-
administered normal rats; fp<0.01 significantly different compared with control rats;
gp<0.01 significantly different compared with glutamine-administered normal rats.S.H.S. Kumar and R. Anandan
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and antiperoxidative enzymes (SOD and CAT) was observed.
The prior administration of glutamine significantly reduced the
isoprenaline induced adverse effects and maintained the level
of evaluated parameters at near normalcy. In Group II rats
the oral administration of glutamine resulted in a significant
(p<0.01) elevation in the level of reduced glutathione.
Discussion
The focus of the current study was to evaluate the effects
of glutamine for its antioxidant and membrane-stabilizing
properties during experimentally induced myocardial injury.
In the present study, there was a significant (p<0.001)
increase noticed in the levels of diagnostic marker enzymes
(ALT, AST, LDH and CPK) in the plasma of Group III
myocardial infarction induced rats as compared to that
of Group I control rats, suggesting the occurrence of
considerable necrotic damage to the myocardial membrane.
This finding concurs with a previous reported study [28],
which indicates that of all the macromolecules leaking from
the damaged cardiac tissue, these enzymes because of their
tissue specificity and catalytic activity are the best markers
of myocardial infarction. The release of these marker
enzymes reflects a non-specific aberration in the structural
and functional integrity of myocardial membrane as a
response to the β-adrenergic stimulation.
In the present study, the prior administration of glutamine
was found to significantly (p<0.001) reduce the release of
the cytosolic enzymes into the systemic circulation, thereby
demonstrating its cytoprotective action on the cell membranes.
The viability of the myocardial cell depends for the most
part on the integrity of several vital subcellular systems and
the major source of energy for contraction comes from the
oxidative metabolism of mitochondria in the myocardial
cell. Glutamine is utilized as a major energy source and
drives mitochondrial ATP formation [29]. The first step for
glutamine catabolism in the mitochondria is its transport
through the inner mitochondrial membrane by a protein-
catalyzed process [30]. Sudden depletion of glutamine has
been reported to result in a sharp decline in mitochondrial
respiration [31]. Our observations also confirm the same
pattern and shows significant (p<0.001) decline in the level
of myocardial ATP content in Group III rats as compared to
that of Group I control animals. Ischemic cells are known to
utilize glutamate for energy production and a fall in tissue
glutamate does occur in the hearts of patients undergoing
coronary artery bypass surgery [12]. In the present study, the
prior administration of glutamine maintained the level of
ATP at near normalcy in Group IV rats as compared to that
of Group III myocardial infarction induced rats, reflecting its
ability to maintain the function of the heart mitochondria at
near normal status. It is possible therefore that in the present
study, the conversion of glutamine to glutamate might have
provided the much-needed substrate for the Krebs cycle
for energy production to counteract isoprenaline-induced
membrane disintegration in the myocardium. Reports by
Dumaswala et al. [32] indicated that glutamine could exert
protective effects on membrane structure by preserving
transmembrane ion gradient and lipid asymmetry.
Oxidative stress is the result of excessive production of
oxygen species and/or depletion of intracellular antioxidant
defenses, leading to imbalance in the redox status of the cell.
A growing body of evidence is emerging which suggests that
reactive oxygen-derived free radicals play a crucial role in
the pathogenesis of myocardial infarction [14]. The effects of
oxidative stress can be evidenced by cellular accumulation
of lipid peroxides. In the present study, a significant rise in
the level of lipid peroxides was noted in the heart tissue
of Group III isoprenaline-administered rats as compared to
that of Group I normal rats. Our findings are in accordance
with earlier reported investigations [15], which indicated
that isoprenaline upon oxidation produces O2−˙ and H2O2.
Peroxidation of endogenous lipids has been shown to be a
major factor in the cardiotoxic action of isoprenaline [33].
Reports by Nirmala and Puvanakrishnan [34] indicated that
lack of antioxidant defense might have resulted in increased
lipid peroxidation and subsequent deleterious effects on
the cardiac membrane in isoprenaline-induced myocardial
Fig. 1.  Level of ATP in the heart tissue of control and experi-
mental groups of rats.
(A): Glutamine, 100 mg/kg body wt/day, p.o. for 20 days.
(B): Isoprenaline, 11 mg/100 g body wt/day, i.p. for 2 days.
Results are mean ± SD for 6 animals. ap<0.001 signifi-
cantly different compared with Group 1 control animals;
bp<0.001 significantly different compared with Group 2
glutamine-administered normal rats; cp<0.001 signifi-
cantly different compared with Group 3 isoprenaline-
induced myocardial infarcted rats; dp<0.01 significantly
different compared with Group 2 animals; ep<0.05
significantly different compared with Group 1 animals.Cardioprotective Effect of Glutamine
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infarction condition.
In the present study, the rats pre-administered with
glutamine showed significant (p<0.001) reduction in the
level of lipid peroxidation in the heart tissue of Group
IV rats as compared with that of Group III myocardial
infarction induced rats, indicating the antioxidant property
of glutamine against isoprenaline-induced lipid peroxidation.
The possible antioxidant effects of glutamine occur through
the formation of nitric oxide. Earlier reports [35] indicated
that nitric oxide derived from donor compounds showed
marked protection against the cytotoxic effects of both
hydrogen peroxide and alkyl hydroperoxide as well as
hypoxanthine/xanthine oxidase-mediated cytotoxicity. NO
released from glutamine either scavenges or prevents the
formation of reactive oxygen species derived from hydrogen
peroxide and superoxide [36]. It can rapidly react with
superoxide anion (O2−˙), which is subsequently protonated
to form OH˙. Previous experimental evidence [37], which
supports the role of NO formed from glutamine as an anti-
oxidant, indicates that the affinity of NO for O2−˙ is greater
than that of SOD for O2−˙. In fact NO from glutamine even
competes with SOD for O2−˙ supporting its role as an anti-
oxidant. Direct action between NO and lipid peroxyl radical
forms a lipid nitroso adduct and this radical-radical interaction
results in the termination of lipid peroxidation chain reaction
and stops further initiation [38]. Earlier Gonzales et al. [39]
reported the antioxidant property of glutamine against cobalt-
induced lipid peroxidation in rat liver.
Glutathione exerts protective antioxidant functions by
reaction with superoxide radicals and peroxy radicals,
followed by the formation of oxidized glutathione and other
disulphides. In the present study, a significant reduction
in the level of reduced glutathione was observed in the
heart tissue of Group III isoprenaline-administered rats as
compared to that of Group I control rats. This was paralleled
by significant decline in the activities of glutathione-dependent
antioxidant enzymes (GPx and GST) and antiperoxidative
enzymes (SOD and CAT) in the heart tissue of Group III
myocardial infarction induced rats. This is consistent earlier
reported studies [15, 40], which indicated that reduction in
the activities of enzymatic and non-enzymatic scavengers
makes myocardial membrane more susceptible isoprenaline-
mediated necrotic damage. Decreases in the activities of
antioxidant enzymes leads to the formation of O2−˙ and H2O2,
which in turn form hydroxyl radical (OH˙) and bring about a
number of reactions harmful to the cellular and subcellular
membranes in the myocardium.
In the present study, the prior oral administration of
glutamine significantly prevented the isoprenaline-induced
depletion of reduced glutathione and maintained the activities
of antioxidant enzymes in the heart tissue of Group IV rats at
near normalcy. A significant rise (p<0.001) in the level of
GSH was noticed in the heart tissue in Group II glutamine
administered rats as compared to that Group I control rats,
Table 2. Levels of lipid peroxides (LPO) and reduced glutathione (GSH) and the activi-
ties of glutathione peroxidase (GPx), glutathione-S-transferase (GST), catalase
(CAT) and superoxide dismutase (SOD) in the heart tissue of normal and exper-
imental groups of rats.
Parameters Control Glutamine (A) Isoprenaline (B) (A + B)
LPO 1.08 ± 0.05 0.87 ± 0.06 2.32 ± 0.18a,b 1.14 ± 0.08c,d,e
GSH 4.76 ± 0.24 6.49 ± 0.37g 2.32 ± 0.11a,b 5.92 ± 0.45c,e,f
GPx 2.43 ± 0.18 2.76 ± 0.24 1.15 ± 0.07a,b 2.30 ± 0.15c,e
GST 1256 ± 94 1345 ± 105 812 ± 64a,b 1118 ± 92c,e
CAT 8.45 ± 0.52 8.93 ± 0.61 3.74 ± 0.21a,b 7.67 ± 0.58c,d,e
SOD 4.15 ± 0.27 4.33 ± 0.25 1.78 ± 0.12a,b 3.83 ± 0.17c,e
(A): Glutamine, 100 mg/kg body wt/day, p.o. for 20 days.
(B): Isoprenaline, 11 mg/100 g body wt/day, i.p. for 2 days.
Results are mean ± SD for 6 animals. Values expressed: LPO, nmol malondialdehyde
released/mg protein; GSH, µmol g−1 wet tissue; GPx, nmol GSH oxidized min−1mg−1
protein; GST, µmol 1-chloro-2,4-dinitrobenzene conjugate formed min−1mg−1 protein;
CAT, nmol H2O2 decomposed min−1mg−1 protein; SOD, one unit of the SOD activity is the
amount of protein required to give 50% inhibition of epinephrine autoxidation ap<0.001
significantly different compared with control animals; bp<0.001 significantly different
compared with glutamine-administered normal rats; cp<0.001 significantly different
compared with isoprenaline-induced myocardial infarcted rats; dp<0.05 significantly
different compared with control animals; ep<0.05 significantly different compared with
glutamine-administered normal rats; fp<0.01 significantly different compared with control
rats; gp<0.001 significantly different compared with glutamine-administered normal rats.S.H.S. Kumar and R. Anandan
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indicating that tissue antioxidant status was operating at a
higher rate in glutamine-treated rats for the counteraction of
lipid peroxides. This finding is in line with an earlier report
[41], which has shown that glutamine is an efficient
precursor of glutathione. There is an experimental basis for
the concept that glutamine may augment the glutathione
system in combating oxidative stress of tissue injury. Models
of gut and liver injury have suggested that supplying an
adequate amount of glutamine can augment the glutathione
system and its ability to combat ischemia reperfusion injury
[42]. Previous studies [43] have also indicated that pre-
injury augmentation of total glutathione may reduce cellular
injury. It has been shown previously that the administration
of glutamine-supplemented nutrition protects the liver and
improves the survival during acetaminophen-induced hepatic
injury in rats, an effect probably due to the maintenance of
liver glutathione [9]. It is also possible that the glutamine
itself may have provided the protective role. Reports by
Karinch et al. [44] have shown that during inflammatory
process, concentrations of glutamine and glutathione are
augmented within the endothelial cell. Our results lead to the
conclusion that a relation may exist between those protective
effects of glutamine and glutathione biosynthesis because
glutathione is a tripeptide consisting of glutamate, cysteine
and glycine.
In conclusion, the results of the present study indicate that
the prior administration of glutamine attenuates isoprenaline-
induced myocardial infarction in rats. The cardioprotective
effect of glutamine is probably related to a strengthening of
the myocardial membrane by its membrane stabilizing action,
or to a counteraction of free radicals by its antioxidant
property, or to its ability to maintain near to normal status the
activities of free radical scavenging enzymes and the level of
GSH, which protect myocardial membrane from oxidative
damage by decreasing lipid peroxidation.
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